NASDAQ:ALZN | Cash Flow Statement | Alzamend Neuro, Inc.

Complete source-backed cash-flow history.

Available history
2020-04-30 to 2026-04-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-04-30-$2.87M-$2.8M$794,844.00
2026-01-31-$2.2M
2025-10-31-$1M
2025-07-31-$2.7M-$2.36M$4.04M
2025-04-30-$1.14M-$688,705.00-$210,000.00$1.49M
2025-01-31-$1.04M
2024-10-31-$1.36M
2024-07-31-$974,411.00-$1.06M-$90,000.00$1.96M
2024-04-30-$851,529.00-$1.43M$0.00$1.52M
2024-01-31-$2.66M
2023-10-31-$2.91M
2023-07-31-$3.53M-$3.3M-$147,243.00
2023-04-30-$3.31M-$2.24M
2023-01-31-$5.43M
2022-10-31-$3.11M
2022-07-31-$3.04M-$2.54M
2022-04-30-$3.87M-$1.56M$3.94M
2022-01-31-$2.57M
2021-10-31-$3.6M
2021-07-31-$2.32M-$1.22M$14.91M
2021-04-30-$1.26M-$1.26M$0.00$3.15M
2021-01-31-$1.12M
2020-10-31-$1.35M
2020-07-31-$1.32M-$205,096.00$100,915.00$77,010.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-04-30-$8.77M-$8.07M$4.83M
2025-04-30-$4.51M-$6.57M-$300,000.00$10.44M
2024-04-30-$9.95M-$8.27M-$147,243.00$3.65M
2023-04-30-$14.88M-$8.92M$200.00
2022-04-30-$12.36M-$6.61M-$106,458.00$18.85M
2021-04-30-$5.05M-$2.71M$100,915.00$4.45M
2020-04-30-$4.41M-$2.35M$105,000.00$2.29M